To enhance the utility of information yielded by Functional Tumor Cell Profiling, Dr. Weisenthal makes available a separately-ordered, written interpretation of testing results.  Board certified in internal medicine and medical oncology, Dr. Weisenthal is able to apply perspective gained over 25 years of providing Functional Tumor Cell Profiling services to hundreds of individual cancer patients and their physicians for use in optimizing therapy selection.  An individual assay interpretation generally runs from two to four pages in length, not including enclosures, and includes such information as the condition of the specimen upon receipt, the behavior of the tumor cells during and after exposure to the various chemotherapy agents, drug activities, including synergies or antagonisms observed, and promising agents or drug combinations that present themselves not only on the basis of in vitro activity but also from what is known about the activities of each drug as reported in the medical literature.  Dr. Weisenthal frankly discusses conditions pertaining to the specimen quality, to the various tests that were performed upon it, and to individual drug behaviors so that important treatment decisions are made on the basis of the fullest possible understanding of the nature and quality of data provided in the profiling report.  Interpretations often include literature citations and/or abstracts and journal reprints relevant to specific test results.